Functional genetic tests of DNA mismatch repair protein activity in Saccharomyces cerevisiae

P Polaczek1, A P Putzke, K Leong

  • 1Bit, Tech Inc., Westlake Village, CA 91361, USA.

Gene
|June 19, 1998
PubMed

Insights

Distinguishing DNA mismatch repair (DMR) gene mutations from polymorphisms is crucial for hereditary non-polyposis colorectal cancer (HNPCC) diagnosis. A yeast-based functional assay successfully identified a specific MSH2 variant as a mutation and another as a polymorphism.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cancer Research

Background:

  • Hereditary non-polyposis colorectal cancer (HNPCC) is linked to DNA mismatch repair (DMR) gene mutations.
  • Many sequence variations in DMR genes cause minor protein alterations, necessitating functional tests to differentiate mutations from polymorphisms.

Purpose of the Study:

  • To develop and validate a functional genetic assay in yeast to assess the impact of sequence variations in human DMR genes.
  • To differentiate between disease-causing mutations and benign polymorphisms in HNPCC-associated genes.

Main Methods:

  • Constructed isogenic yeast strains with disrupted DMR genes (MSH2, MLH1, PMS1).
  • Standardized a GT tract stability assay to measure DNA mismatch repair efficiency.
  • Utilized site-directed mutagenesis to introduce human MSH2 variants into yeast MSH2.

Main Results:

  • Disruption of yeast MSH2, MLH1, and PMS1 genes caused significant increases in GT tract instability.
  • A Pro640Leu substitution in yeast MSH2 abolished protein function, indicating a mutation.
  • A His658Tyr substitution in yeast MSH2 retained full function, indicating a polymorphism.

Conclusions:

  • The developed yeast assay can functionally distinguish between disease-causing mutations and polymorphisms in DMR genes.
  • The Pro640Leu variant is a mutation, while the His658Tyr variant is a polymorphism in the human MSH2 gene.
  • This system provides a platform for further structure-function analysis of DMR proteins and their variants.